Stem cells as an option for the treatment of COVID-19

TO THE EDlTOR

The current pandemic we are experiencing due to coronavirus disease 2019 (COVID-19) undoubtedly represents a significant challenge for medical and research domains. The magnitude of the disease is evident with millions of lives lost; therefore, the need to find appropriate treatment is urgent. One of the main effects that this type of virus triggers in the human body is the overproduction of pro-inflammatory cytokines [interleukins (ILs)], such as IL-1α/β, IL-2, IL-6, IL-12, interferon (IFN)-α/β/γ, and the anti-tumor necrosis factor (TNF), which cause damage to multiple organs[1]. Zheng[2] published a very interesting study in which they carried out a review of the effects of stem cells in the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It covers the ability of stem cells to secrete immunomodulatory factors and to improve the adverse effects of respiratory syndrome by reducing fibrosis.

Since the first umbilical cord stem cell transplant for the treatment of Fanconi anemia[3], the use of stem cells for the treatment of multiple diseases, including COVID-19, has increased. Among the various positive effects of stem cells is their capacity for immunoregulation by controlling inflammatory processes. The evidence we have on the use of stem cells for the SARS-CoV-2 infection is from transplanting mesenchymal cord cells by intravenous infusion, in which there is a significant decrease in the cytokines granulocyte-macrophage colony-stimulating factor, IFN-γ, IL-5, IL-6, IL-7, TNF-α, TNF-,platelet-derived growth factor-BB, and RANTES, which in turn decrease the mortality rate and the recovery time of patients[4]. Also, the application of umbilical stem cells has shown—through imaging analysis—that it improves the damage to lung tissue by reducing the solid component, which may be related to fibrosis[5].

Stem cells influence the regulation of cytokine expression by promoting the polarization of macrophages from a pro-inflammatory to an anti-inflammatory phenotype through the production of different types of cytokines, such as prostaglandin E2, TNF-stimulated gene 6 protein lactate, kynurenic acid, and spermidine, all of which in turn have an effect on the adaptive immune system by preventing the activation of effector T cells and promoting the regulation of regulatory T cells[6].

The efficacy and safety of the application of stem-cell-derived microvesicles have also been evaluated,which improve the oxygenation conditions of patients, thereby avoiding mechanical oxygenation methods and demonstrating the ability to modulate the inflammatory response by reducing the levels of proinflammatory cytokines within the first few hours of their intravenous application[7]. This is because these microvesicles contain cytokines, growth factors, and microRNAs that function as anti-inflammatory agents[8].

Oh, he was excited! Now Justin had a way to know when his new baby sister would come to play. From that moment on, he checked the old plum tree several times a day and reported his findings to me. Of course, he was quite concerned in November when all the leaves fell off the tree. By January, with the cold and the rains, he was truly worried whether his baby would be cold and wet like his tree. He whispered to my tummy that the tree was strong and that she (the baby) had to be strong too, and make it through the winter.

Mexico

I am grateful for your goodwill25, but take back your gift! The fairy had pity on his youth and want of faith, and took care that one end of the thread remained in his hand

Cuevas-González MV and Cuevas-González JC wrote the manuscript.

Maria Veronica Cuevas-González 0000-0003-3112-4893; Juan Carlos Cuevas-González 0000-0002-6981-8025.

FOOTNOTES

While they were looking, two feelers poked7 out from the cavity. They were attached to a kind of brown knob-head, which followed the feelers, and then two large legs took a strong grip on the edge of the cavity and hoisted8 some of the rest of whatever it was out of the seed, and stopped there a moment, as if to look around.

This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

None.

Although clinical trials have shown that stem-cell-based therapy has great advantages that have a direct impact on the survival of patients with severe disease, there are significant technical and biological limitations with this type of therapy: (1) The methods of obtaining stem cells—for example,those that come from adults; and (2) The quantity and quality of these stem cells depend on the age of the donor and their exposure to environmental stress, which could affect cell proliferation and differentiation[9]. Obtaining stem cells is still a challenge due to the lack of consensus of ethics committees.Another major challenge is themanipulation given to the cells: Keeping them in expansion for long periods of time can limit the characteristics of the cells regarding their regeneration potential and genomic stability[10].

The conclusion of this Letter is that although encouraging results have been obtained, we believe it is necessary to continue with long-term clinical trials that (1) Include a greater number of patients that allow adequate evaluation; (2) Design studies with a longer follow-up time, months or years, which allows an adequate assessment of the possible biological risks of the application of stem cells; and (3)Include the evaluation of molecular studies in order to analyze the gene expression of stem cells within the body These three clinical trial points will aid in obtaining approval from the international institutions that sanction the use of medical drugs (including stem cells).

Fan JR

” “But if you take away my voice,” said the little mermaid, “what is left for me?” “Your beautiful form, your graceful87 walk, and your expressive89 eyes; surely with these you can enchain a man’s heart

Filipodia

Fan JR